Renova Hospitals

What Renova Hospitals does

Renova Hospitals is a privately held, founder-led Indian multispecialty hospital network founded in 2019 and headquartered in Hyderabad. It operates 11–12 NABH-accredited facilities with a stated combined capacity of 2,000+ beds and 1,500+ medical professionals (including 500+ doctors) across Telangana, Rajasthan, and Andhra Pradesh, organized around five specialty institutes (Onco Sciences, Gastro Sciences, Orthopaedics & Robotic Surgery, Neurological Sciences, and Cardiac Sciences). The network is oncology-anchored — 8 of the 11–12 centres are dedicated or joint cancer centres — and combines medical, surgical, and radiation oncology with adjacent multispecialty departments (cardiology, neurology, nephrology, orthopedics, critical care).

Its core technology stack comprises advanced radiotherapy platforms (Hyderabad's first TrueBeam with HyperArc for sub-millimetre precision and the Halcyon system delivering 4x faster treatment cycles), Hyperthermic Intraperitoneal Chemotherapy (HIPEC) surgery, Bone Marrow Transplant and CAR-T cell therapy, robotic-assisted surgery, and a digitally enabled booking and callback layer. Every oncology patient has 24/7 in-house access to cardiology, nephrology, and ICU — an integrated safety net that standalone cancer centres cannot replicate. The company reports 200,000+ chemotherapy sessions and 2 lakh+ recoveries cumulatively.

Revenue is generated almost entirely on a transaction/fee-for-service basis from inpatient admissions, outpatient consultations, surgical procedures, diagnostics/laboratory services, and radiation/medical oncology, collected via direct patient payments, empanelment with Telangana's Aarogyasri scheme and Employee Health Scheme (EHS), and all major insurance providers. Go-to-market is direct-to-consumer through 11–12 hospital walk-in locations, a website/WhatsApp booking channel, and a 24/7 phone line, with a nascent international patient program. Pricing is not publicly disclosed and is quote-based by specialty and complexity.

Name

Renova Hospitals

Legal name

Renova Hospitals

Website

https://renovahospitals.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Renova Hospitals is a Hyderabad-based private multispecialty and oncology hospital network operating 11–12 NABH-accredited facilities with 2,000+ beds across Telangana, Rajasthan, and Andhra Pradesh, serving cancer and multispecialty patients via advanced radiotherapy, surgical oncology, and government/insurance empanelment.

Ownership category

akta.pro rank

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices13 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Patient Care Services: Primary revenue stream from inpatient admissions, outpatient consultations, surgical procedures, diagnostic services, radiation oncology, chemotherapy, and ICU care across all hospital locations
2. Diagnostic and Laboratory Services: Revenue from imaging (radiology), pathology, nuclear medicine, and other diagnostic investigations performed at hospital facilities
3. Insurance and Government Schemes: Revenue collected through empanelment with Aarogyasri, EHS (Employee Health Scheme), and all major insurance providers, serving as a significant payment channel for patients

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Renova Hospitals operates a network of 11–12 NABH-accredited multi-specialty and cancer care hospitals across Telangana, Rajasthan, and Andhra Pradesh, delivering oncology, cardiac, neuro, ortho, gastro, and emergency services. Core clinical offerings include medical, surgical, and radiation oncology with TrueBeam HyperArc and Halcyon radiotherapy, HIPEC surgery, bone marrow transplant and CAR-T cell therapy, robotic surgery, and organ transplant programs. The network is empanelled with Aarogyasri, EHS, and major insurance providers, with integrated 24/7 Cardiology, Nephrology, and ICU support for every oncology patient.

Product overview

Renova Hospitals is a multi-specialty hospital network operating 12 NABH-accredited facilities across Telangana, Rajasthan, and Andhra Pradesh, India. Founded in 2019 and headquartered in Hyderabad, the network spans general and specialty hospitals including dedicated cancer centres (Renova Soumya Cancer Centre, RHL Renova Cancer Centre Jaipur, DDH Renova Cancer Centre, Harish Renova Cancer Centre Alwar, KIMS Renova Cancer Institute Vizag, and others). The network's clinical portfolio includes Centres of Excellence in oncology (Renova Institute of Onco Sciences), gastro sciences, orthopaedics & robotic surgery, neurological sciences, and cardiac sciences. Key advanced technology offerings include TrueBeam HyperArc radiotherapy, the Halcyon radiotherapy system, HIPEC surgery, bone marrow transplant & CAR-T cell therapy, and robotic surgery. The integrated care model provides every oncology patient with in-house cardiology, nephrology, and ICU support. The network reports over 2,00,000 chemotherapy sessions and claims a track record of 2 lakh+ recoveries.

Differentiator

Problem solved

Functional benefit

Brands

• Renova Institute of Gastro Sciences (RIGS): Specialized institute focused on gastroenterology and digestive sciences
• Renova Institute of Orthopaedics & Robotic Surgery (RIOR)
• Renova Institute of Neurological Sciences (RINS)
• Renova Heart Institute (RHI)
• Renova Institute of Onco Sciences (RIOS)

Products and services

• TrueBeam HyperArc Radiotherapy Advanced radiation therapy service enabling sub-millimeter precision tumour targeting, deployed as Hyderabad's first TrueBeam with HyperArc installation at Renova Hospitals' Hyderabad facility. Targeted at cancer patients requiring high-precision radiotherapy with minimal damage to surrounding healthy tissue.
• Halcyon Radiotherapy Advanced radiotherapy service delivering treatment 4x faster than conventional radiation systems while ensuring maximum tumour destruction. Targets cancer patients seeking shorter, more comfortable radiation therapy sessions.
• HIPEC Surgery (Hyperthermic Intraperitoneal Chemotherapy) Hyperthermic Intraperitoneal Chemotherapy surgical procedure pioneered as the first-ever HIPEC surgery in East Hyderabad at Durgabai Deshmukh Renova Cancer Centre. Combines heated chemotherapy with surgery for patients with advanced abdominal and peritoneal cancers.
• Bone Marrow Transplant (BMT) and CAR-T Cell Therapy Advanced hematology-oncology services including bone marrow transplant and CAR-T cell therapy for blood cancers and related disorders. Delivered through the Hemato-Oncology & BMT department.
• Robotic Surgery Robotic-assisted surgical procedures including orthopaedic robotic surgery and general robotic surgery. Delivered across multiple hospital locations for precision surgical interventions with faster recovery times.
• Renova Institute of Onco Sciences (RIOS) Centre of Excellence covering medical oncology, surgical oncology, radiation oncology, and haemato-oncology. Backed by 24/7 in-house Cardiology, Nephrology, and ICU support for every oncology patient.
• Renova Heart Institute (RHI) Cardiac Centre of Excellence offering cardiology, cardiothoracic surgery, and heart transplant services as part of the Renova network.
• Renova Institute of Gastro Sciences (RIGS) Centre of Excellence focused on gastroenterology, surgical gastroenterology, and digestive sciences within the Renova network.
• Renova Institute of Orthopaedics & Robotic Surgery (RIOR) Orthopaedic Centre of Excellence offering ortho robotic surgery, arthroplasty and sports medicine, and related musculoskeletal care within the Renova network.
• Renova Institute of Neurological Sciences (RINS)

Quantifiable outcome

• 2,00,000+ chemotherapy sessions performed by world-class oncologists
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Cancer Centers of America (CCA)minorOthers · 9 July 2026Cancer Centers of America (led by Raj Mantena) is the competing bidder in the race to acquire Siemens Healthineers' American Oncology Institute. This is a competitive bidder relationship, not a partnership with Renova.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Fortis Healthcare: Large multispecialty hospital network with oncology and critical-care programmes. Comparable model of integrated cancer care within a multispecialty footprint.
• Apollo Hospitals: Largest multispecialty hospital chain in India with flagship oncology programmes. Overlaps with Renova on cancer care and multispecialty coverage, but operates at much larger per-hospital scale and broader geography.
• Max Healthcare: Major North Indian multispecialty and oncology hospital chain. Comparable integrated multispecialty-plus-oncology model with NABH-accredited tertiary centres.
• Manipal Hospitals: Pan-India multispecialty chain with significant tertiary and oncology capabilities. Overlaps with Renova on multispecialty breadth and urban hospital positioning.
• Shalby Limited: Multispecialty and orthopaedics-focused hospital chain across India. Comparable multispecialty model; notably Renova's new HR Head previously worked at Shalby, indicating overlapping talent and operating playbooks.

Direct peers

• Healthcare Global Enterprises (HCG): India's largest dedicated cancer-care hospital chain. Directly comparable as a specialty oncology network competing for the same patient segments and advanced-radiotherapy positioning that Renova targets.
• American Oncology Institute: Siemens Healthineers-owned oncology network currently targeted by Renova's consortium for acquisition. Directly comparable as a cancer-hospital chain with multi-city presence in India.
• Cancer Centers of America: US-headquartered competing bidder for AOI and a peer specialty oncology operator. Directly comparable in oncology-only hospital model and now competing for the same asset Renova is bidding on.

Regional players

• KIMS Hospitals: South Indian (Telangana/AP-focused) multispecialty chain that already partners with Renova on the KIMS Renova Cancer Institute in Vizag. Direct overlap in core Telugu-speaking geographies.
• Medicover Hospitals: Multispecialty hospital chain with strong Telangana/AP presence. Comparable regional multispecialty positioning competing for the same patient base in core Renova markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/RenovaHospitals
• Facebookfacebook.com/renovahospitals
• LinkedInlinkedin.com/company/renova-hospitals

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Renova Hospitals